Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2016

Open Access 01-12-2016 | Research article

Systematic review of the health and societal effects of medication organisation devices

Authors: Steven James Watson, Clare Frances Aldus, Christine Bond, Debi Bhattacharya

Published in: BMC Health Services Research | Issue 1/2016

Login to get access

Abstract

Background

Suboptimal medication adherence is a significant threat to public health and resources. Devices that organise weekly doses by time and day are commonly used to reduce unintentional non-adherence. However, there is limited evidence to support their use. This systematic review was conducted to evaluate current evidence for their efficacy, safety and costs.

Methods

A pre-defined search of electronic databases from inception to January 2013 augmented with hand-searching was conducted. No limits were placed on publication date. Studies that compared organisation devices used by patients administering their own medication with standard medication packaging regardless of study design were eligible for inclusion. Studies that solely explored dispensing aspects of organisation devices were included whether or not they compared this to standard care. Screening of articles for inclusion and data extraction were completed independently by two reviewers with disagreements resolved by discussion. Outcomes were categorised into impact on health, medication adherence, healthcare utilisation, dispensing errors, supply procedures and costs. Risk of bias was also assessed.

Results

Seventeen studies met the inclusion criteria. Health outcomes were investigated in seven studies of which three reported a positive effect associated with organisation devices. Medication adherence was reported in eight studies of which three reported a positive effect. Three studies reported health care utilisation data but overall results are inconclusive. No optimal dispensing or supply procedures were identified. Economic assessment of the impact of organisation devices is lacking. All studies were subject to a high risk of bias.

Conclusions

Evidence regarding the effects of medication organisation devices was limited, and the available evidence was susceptible to a high risk of bias. Organisation devices may help unintentional medication non-adherence and could improve health outcomes. There is a strong need for more studies that explore the impact of such devices on patients, and an equally pressing need for studies that explore the impacts on healthcare services.

Trial registration

This systematic review is registered with PROSPERO (Registration number CRD42011001718).
Literature
1.
DiMatteo MR. Variations in patients’ adherence to medical recommendations - A quantitative review of 50 years of research. Med Care. 2004;42(3):200–9.CrossRefPubMed
2.
Sackett DL, Snow JC. The magnitude of compliance and noncompliance. In: Haynes RB, Taylor DW, Sackett DL, editors. Compliance in Health Care. London: John Hopkins University Press; 1979. p. 11–22.
3.
Horne R. Nonadherence to medication: Causes and implications for care. In: Gard P, editor. A Behavioural Approach to Pharmacy Practice. London: Blackwell Science; 2000.
4.
Atkins L, Fallowfield L. Intentional and non-intentional non-adherence to medication amongst breast cancer patients. Eur J Cancer. 2006;42(14):2271–6.CrossRefPubMed
5.
DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes a meta-analysis. Med Care. 2002;40(9):794–811.CrossRefPubMed
6.
National Institute for Clinical Excellence. Costing statement: Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. In: National Institute for Health and Clinical Excellence. 2009. p. 3.
7.
8.
9.
Nunney JM, Raynor DKT. How are multi-compartment compliance aids used in primary care? Pharm J. 2001;267(7176):784–9.
10.
Mahtani KR, Heneghan CJ, Glasziou PP, Perera R. Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Syst Rev. 2011;9(9):Cd005025.
11.
Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996;348(9024):383–6.CrossRefPubMed
12.
Morrison A, Wertheimer AI, Berger ML. Interventions to improve antihypertensive drug adherence: a quantitative review of trials. Formulary. 2000;35(3):234–55.
13.
Boeni F, Spinatsch E, Suter K, Hersberger KE, Arnet I. Effect of drug reminder packaging on medication adherence: a systematic review revealing research gaps. Syst Rev. 2014;3:29.CrossRefPubMedPubMedCentral
14.
Pamboukian SV, Nisar I, Patel S, Gu L, McLeod M, Costanzo MR, Heroux A. Factors associated with non-adherence to therapy with warfarin in a population of chronic heart failure patients. Clin Cardiol. 2008;31(1):30–4.CrossRefPubMed
15.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:332–6.CrossRef
16.
Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions, version 5.0.2. Cochrane Collaboration. 2009.
17.
Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074–90.CrossRefPubMed
18.
Roberts M. Effectiveness and cost effectiveness of dose administration AIDS (DAAS). Brisbane: Pharmacy Guild of Australia; 2004.
19.
McElnay J, Thompson J. Dispensing of medicines in compliance packs. Int Pharm J. 1992;6(1):10–4.
20.
Becker LA, Glanz K, Sobel E, Mossey J, Zinn SL, Knott KA. A randomized trial of special packaging of antihypertensive medications. J Fam Pract. 1986;22(4):357–61.PubMed
21.
Feetam C, Kelly D. An assessment of a new compliance aid: the Medidos. Br J Pharm Pract. 1982;4:5–12.
22.
Wong BS, Norman DC. Evaluation of a novel medication aid, the calendar blister-pak, and its effect on drug compliance in a geriatric outpatient clinic. J Am Geriatr Soc. 1987;35(1):21–6.CrossRefPubMed
23.
Huang HY, Maguire MG, Miller 3rd ER, Appel LJ. Impact of pill organizers and blister packs on adherence to pill taking in two vitamin supplementation trials. Am J Epidemiol. 2000;152(8):780–7.CrossRefPubMed
24.
Petersen ML, Wang Y, van der Laan MJ, Guzman D, Riley E, Bangsberg DR. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis. 2007;45(7):908–15.CrossRefPubMedPubMedCentral
25.
Rehder TL, McCoy LK, Blackwell B, Whitehead W, Robinson A. Improving medication compliance by counseling and special prescription container. Am J Hosp Pharm. 1980;37(3):379–85.PubMed
26.
Simmons D, Upjohn M, Gamble GD. Can medication packaging improve glycemic control and blood pressure in 2 diabetes? Results from a randomized controlled trial. Diabetes Care. 2000;23(2):153–6.CrossRefPubMed
27.
Crome P, Curl B, Boswell M, Corless D, Lewis RR. Assessment of a new calendar pack—the ‘C-PAK’. Age Ageing. 1982;11(4):275–9.CrossRefPubMed
28.
MacIntosh P, Pond G, Pond B, Leung V, Siu L. A comparison of patient adherence and preference of packaging method for oral anticancer agents using conventional pill bottles versus daily pill boxes. Eur J Cancer Care. 2007;16(4):380–6.CrossRef
29.
Ryan-Woolley BM, Rees JA. Initializing concordance in frail elderly patients via a medicines organizer. Ann Pharmacother. 2005;39(5):834–9.CrossRefPubMed
30.
Skaer TL, Sclar DA, Markowski DJ, Won JK. Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures--a study of patients with non-insulin-dependent diabetes mellitus. J Clin Pharm Ther. 1993;18(4):295–9.CrossRefPubMed
31.
Skaer TL, Sclar DA, Markowski DJ, Won JK. Effect of value-added utilities on prescription refill compliance and health care expenditures for hypertension. J Hum Hypertens. 1993;7(5):515–8.PubMed
32.
Carruthers A, Naughton K, Mallarky G. Accuracy of packaging of close administration aids in regional aged care facilities in the Hunter area of New South Wales. Med J Aust. 2008;188(5):208–82.
33.
Levings B, Szep S, Helps SC. Towards the safer use of dosettes. J Qual Clin Pract. 1999;19(1):69–72.CrossRefPubMed
34.
Stewart D, Ogilvie E, Kennedy E, Hansford D, Neil E. Medication compliance devices in primary care: Activities of community-based nurses. Int J Pharm Pract. 2001;9(2):91–5.CrossRef
35.
Cate H, Bhattacharya D, Clark A, Holland R, Broadway DC. A comparison of measures used to describe adherence to glaucoma medication in a randomised controlled trial. Clin Trials. 2015;12(6):608–17.CrossRefPubMed
36.
37.
Insel KC, Cole L. Individualizing memory strategies to improve medication adherence. Appl Nurs Res. 2005;18(4):199–204.CrossRefPubMed
38.
Insel KC, Einstein GO, Morrow DG, Hepworth JT. A multifaceted prospective memory intervention to improve medication adherence: Design of a randomized control trial. Contemp Clin Trials. 2013;34(1):45–52.CrossRefPubMed
39.
Gordis L. Conceptual and methodologic problems in measuring patient compliance. In: Haynes RB, Taylor DW, Sackett DL, editors. Compliance in Health Care. edn. London: John Hopkins University Press; 1979.
40.
Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261(22):3273–7.CrossRefPubMed
41.
Gallagher PF, O'Connor MN, O'Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using stopp/start criteria. Clin Pharmacol Ther. 2011;89(6):845–54.CrossRefPubMed
42.
Metadata
Title
Systematic review of the health and societal effects of medication organisation devices
Authors
Steven James Watson
Clare Frances Aldus
Christine Bond
Debi Bhattacharya
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2016
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-016-1446-y

Other articles of this Issue 1/2016

BMC Health Services Research 1/2016 Go to the issue

Research article

Context, mechanisms and outcomes of integrated care for diabetes mellitus type 2: a systematic review

Research article

Determinants of aggregate length of hospital stay in the last year of life in Switzerland

Research article

Shifting human resources for health in the context of ART provision: qualitative and quantitative findings from the Lablite baseline study

Research article

“Perspectives on financing population-based health care towards Universal Health Coverage among employed individuals in Ghanzi district, Botswana: A qualitative study”

Review

Technological aids for improving longitudinal research on substance use disorders

Research article

Perceived coercion to enter treatment among involuntarily and voluntarily admitted patients with substance use disorders